Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment-Reference-Cited by-同舟云学术

Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment

Published:2012-03-22 Issue:4 Volume:52 Page:707-714
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:

Author:

Dahlöf Carl,Maassen Van Den Brink Antoinette

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-4610.2012.02124.x/fullpdf

Reference70 articles.

1. Cardiovascular responses produced by 5-hydroxytriptamine: A pharmacological update on the receptors/mechanisms involved and therapeutic implications;Villalón;Naunyn-Schmiedebergs Arch Pharmacol,2007

2. Barnes NM Andrade R Bockaert J et al 5-Hydroxytryptamine receptors, introductory chapter IUPHAR database (IUPHAR-DB ). http://www.iuphar-db.org/DATABASE/FamilyIntroductionForward?familyId=1

3. The molecular evolution of G protein-coupled receptors: Focus on 5-hydroxytryptamine receptors;Peroutka;Neuropharmacology,1994

4. Pathophysiology of migraine - new insights;Hargreaves;Can J Neurol Sci,1999

5. Wolff Award presentation 1993. Anti-migraine drug interactions with cloned human 5-hydroxytryptamine1 receptor subtypes;Peroutka;Headache,1993

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-09-12

2. Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity;Molecular Neurobiology;2024-08-12

3. Preclinical mitigation of 5-HT2B agonism-related cardiac valvulopathy revisited;Journal of Pharmacological and Toxicological Methods;2024-07

4. Identifying potential drug targets in the kinomes of two monogenean species;Helminthologia;2024-06-01

5. Neurophysiological and Vascular Mechanisms of Action of Serotoninergic Drugs for Abortive Migraine Treatment;Neuroscience and Behavioral Physiology;2024-06